Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus

Author： Katsiki Niki   Mikhailidis Dimitri P   Gotzamani-Psarrakou Anna   Yovos John G   Karamitsos Dimitrios  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.4, 2011-04, pp. : 401-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valsartan Increases Circulating Adiponectin Levels without Changing HOMA-IR in Patients with Type 2 Diabetes Mellitus and Hypertension

By Lee J-M   Kim J-H   Son H-S   Hong E-G   Yu J-M   Han K-A   Min K-W   Chang S-A  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 234-241

Field House Publishing

Access to resources Recommend Favorite

The Pharmaceutical care of patients with type 2 diabetes mellitus

By Borges Anna  

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 730-736

Springer Publishing Company

Access to resources Recommend Favorite

Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 10, 2015-01 ,pp. : 853-870

Bentham Science Publishers

Access to resources Recommend Favorite

Blood Pressure-Lowering Effect of Nebivolol in Hypertensive Patients with Type 2 Diabetes Mellitus: The YESTONO Study

By Schmidt Andre C.  

Clinical Drug Investigation, Vol. 27, Iss. 12, 2007-01 ,pp. : 841-849

Adis International

Access to resources Recommend Favorite

Adiponectin in Diabetes Mellitus

By  

Current Medicinal Chemistry, Vol. 19, Iss. 32, 2012-11 ,pp. : 5451-5458

Bentham Science Publishers

Access to resources Recommend Favorite